MedTrace Logo

Primary Breast Cancer Occurring Concomitant With Pregnancy

NCT00510367 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2020-07-10

No results posted yet for this study

Summary

The goal of this clinical research study is to learn the results of multimodality (chemotherapy, surgery and radiation therapy) treatment of primary breast cancer that occurs at the same time as pregnancy. Researchers want to evaluate the outcome of labor and delivery as well as evaluate the long-term health outcomes of children exposed to chemotherapy while in their mother's womb.

Conditions

Interventions

DRUG

5-Fluorouracil

500 mg/m\^2 By Vein Daily x 2 Days

DRUG

Cyclophosphamide

500 mg/m\^2 By Vein On Day 1

DRUG

Doxorubicin

50 mg/m\^2 By Vein Over 72 Hours

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Jennifer Litton, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-08-07
Primary Completion
2020-07-08
Completion
2020-07-08
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00510367 on ClinicalTrials.gov